|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.412 USD | +0.15% |
|
+3.07% | -29.04% |
| Apr. 26 | Exagen Inc. Announces Changes in Board of Directors | CI |
| Mar. 18 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Exagen Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 11.23 million compared to USD 10.39 million a year ago. Net loss was USD 7.69 million compared to USD 10.27 million a year ago.
Basic loss per share from continuing operations was USD 0.44 compared to USD 0.6 a year ago. Diluted loss per share from continuing operations was USD 0.44 compared to USD 0.6 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.04% | 24.51M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +11.62% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
EXAGEN INC. 
